This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
Longeveron initiates phase 2b stem cell therapy trial to treat ageing frailty
Longeveron LLC, a regenerative medicine company developing cellular therapies, announced that it treated its first patient in the Company’s Phase 2b clinical trial evaluating the safety and efficacy of Longeveron